Evidence map›Paper›PMID 34191165›Full record

ArticleEuropean journal of hybrid imaging2020

Alaa Mouminah, Austin J Borja, Emily C Hancin, Yu Cheng Chang, Thomas J Werner, Samuel Swisher-McClure, Jonathan Korostoff, Abass Alavi, Mona-Elisabeth Revheim

Open access · goldAbstract read
In one paragraph

Article in European journal of hybrid imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alaa MouminahDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Austin J BorjaDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Emily C HancinDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Yu Cheng ChangThe University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA.
Thomas J WernerDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Samuel Swisher-McClureDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Jonathan KorostoffThe University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA.
Abass AlaviDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Mona-Elisabeth RevheimDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA. mona.elisabeth.revheim@ous-hf.no.ORCID http://orcid.org/0000-0003-3300-7420
University of Pennsylvania · USOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThis retrospective study included patients with HNC treated with photon, proton, or combined photon/proton RT, in addition to chemotherapy. All patients received FDG-PET/CT imaging pre-treatment and 3 months post-treatment. The average mean standardized uptake value (Avg SUVmean) and the average maximum standardized uptake value (Avg SUVmax) of the left and right parotid glands were determined by global assessment of FDG activity using OsiriX MD software. A two-tailed paired t test was used to compare Avg SUVmean and Avg SUVmax pre- and post-RT.

resultsForty-seven HNC patients were included in the study. Parotid gland Avg SUVmean was significantly higher at 3 months post-treatment than pre-treatment (p < 0.05) in patients treated with photon RT, but no significant differences were found between pre- and post-treatment Avg SUVmean in patients treated with proton RT or combined photon/proton RT.

conclusionOur results suggest that photon RT may cause radiation-induced inflammation of the parotid gland, and that proton RT, which distributes less off-target radiation, is a safer treatment alternative.

Indexed as

18F-FDGHead and neck cancerParotid glandParotid gland inflammationPET/CTRadiation therapy

Identifiers

PMID34191165
PMCPMC8218117
OpenAlexW3110143250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.